UNSPSC 51287004: Dapsone

This classification denotes a sulfone anti-infective agent with the molecular formula C12H12N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8W5C518302, chemically known as 4,4-sulphonyldianiline but more generally known as dapsone, which bears US NIH Compound Identifier 2955. European Medicines Agency schedules Dapsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06909MIG. The term DAPSONE is an International Non-Proprietary Name.

The World Health Organization schedules dapsone in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N.

UNSPSC 51287004 Dapsone, a Commodity code, nominally identifies a single antimicrobial pharmaceutical product but maps poorly to the state and local procurement activity currently tagged under it. Recent solicitations under this code acquire naloxone kits, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals distributed through cooperative purchasing alliances, and direct-to-manufacturer prescription fulfillment capabilities—none of which are dapsone or fit the code's stated scope. State and local buyers using this code tag include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance administering contracts across member states including Oregon). The mismatch between code definition and actual procurement suggests either a cataloging error in state and local systems or a catch-all application of the code to diverse pharmaceutical acquisitions that should resolve to more specific commodity classifications.

Geographic activity centers on Florida, Texas, and Minnesota, with the most substantive recent procurements originating from established cooperative purchasing vehicles and state agencies. The City of Tampa issued an IFB for medical and first aid supplies (Bid 26-P-00145) due March 13, 2026, seeking 169 line items valued at approximately $700,000 and restricted to certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking annual procurement of naloxone kits and drug deactivation systems with quarterly deliveries. Minnesota's MMCAP alliance issued an RFP (S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, effective July 1, 2026. The Texas HHS Commission issued an exploratory RFI (HHS0017013) in April 2026 to gather vendor capability data on direct-to-manufacturer prescription programs before formal solicitation. This code shows limited coherence as a reliable procurement indicator; businesses should verify their product fit against specific issuing-body requirements rather than relying on the nominal dapsone classification.